Skip to main content
  • Login
  • Contact
  • Subscriptions

Search form

Home

Deer Park Tribune

Deer Park weather

  • Home
  • News
  • Sports
  • Obituaries
  • Entertainment
    • Special Sections
    • Talking About...
  • Photos
  • Videos
  • Classifieds
    • Classified Display Ads
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acadia Pharmaceutica (NQ: ACAD )

49.56 USD UNCHANGED
Streaming Delayed Price Updated: 7:09 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 49.56
Bid (Size) 45.27 (1)
Ask (Size) 51.93 (1)
Prev. Close 49.56
Today's Range 49.56 - 49.56
52wk Range 30.02 - 58.72
Shares Outstanding 124,825,969
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
February 24, 2021
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced financial results for the fourth quarter and full year ended December 31, 2020. 
From Business Wire News Releases
Acadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com
February 19, 2021
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the launch of MoreThanMemoryLoss.com, a new website with educational resources designed to help caregivers and people living with dementia to... 
From Business Wire News Releases

Performance

YTD
-6.15%
-6.15%
1 Month
+6.40%
+6.40%
3 Month
-12.53%
-12.53%
6 Month
+25.18%
+25.18%
1 Year
+13.25%
+13.25%

More News

Read More
Acadia Pharmaceuticals to Present at Upcoming Investor Conferences
February 18, 2021
From Business Wire News Releases
Noteworthy ETF Inflows: LABU, ALXO, ACAD, XLRN
February 26, 2021
Tags ETFs
From ETF Channel
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
February 10, 2021
From Business Wire News Releases
ROCE Insights For ACADIA Pharmaceuticals
February 25, 2021
Tags News BZI/ROCE Market News
From Benzinga
Recap: ACADIA Pharmaceuticals Q4 Earnings
February 24, 2021
Tags Earnings Benzinga ACAD
From Benzinga
Acadia Pharmaceuticals Announces Commercial Leadership Change
January 27, 2021
From Business Wire News Releases
A Preview Of ACADIA Pharmaceuticals's Earnings
February 23, 2021
Tags BZI/EP ACAD Earnings
From Benzinga
Shuman Glenn & Stecker Investigates Acadia Pharmaceuticals, Inc.
January 11, 2021
From Business Wire News Releases
Analysts Expect FXH Will Reach $120
February 23, 2021
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2020 The Deer Park Tribune | 104 N. Main Street | Deer Park, WA 99006 | (509) 276-5043
All property rights for the entire contents of this publication shall be the property of The Deer Park Tribune.
No part hereof may be reproduced without prior written consent.
Privacy and Terms of Use


Site Design, Programming & Development by Surf New Media